Hamilton Capital Partners (Canada)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hamilton Capital Partners (Canada)'s AMGN Position: Q2 2026 in Review
Hamilton Capital Partners (Canada) increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $1.06M and bringing the position to 21,267 shares worth $7.7M. The position accounts for 0.22% of the portfolio, ranked #81.
Hamilton Capital Partners (Canada) first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hamilton Capital Partners (Canada) held 21,267 shares of Amgen worth $7.7M as of Q2 2026.
- Hamilton Capital Partners (Canada) bought 3,094 Amgen shares in Q2 2026, an estimated $1.06M.
- Amgen made up 0.22% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #81 holding.
- Hamilton Capital Partners (Canada) first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
- 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.